Preparation and evaluation of optimized zolmitriptan niosomal emulgel

References

• Zhang YH, A Campbell S, Karthikeyan S. Finite element analysis of hollow out-of-plane HfO2 micro-needles for transdermal drug delivery applications. J Biomed Microdevices. 2018;20(1):19.
   PubMed Web of Science ®Google Scholar
• Yin Z, Kauang D, Zheng Z, et al. Swellable silk fibroin microneedles for transdermal drug delivery. Int J Biol Macromol. 2018;106:48–56.
   PubMed Web of Science ®Google Scholar
• Qumbar M, Ameeduzzafar, Iman S, et al. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: in-vitro characterization and in-vivo activity. J Biomed Pharmacother. 2017;93:255–266.
   PubMed Web of Science ®Google Scholar
• Kassem AA, Abd El-Alim SH, Asfour MH. Enhancement of 8-methoxypsoralen topical delivery via nanosized niosomal vesicles: formulation development, in vitro and in vivo evaluation of skin deposition. Int J Pharm. 2017;517(1-2):256–268.
   PubMed Web of Science ®Google Scholar
• Uchegbu I, Vyas S. Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm. 1998;172(1): 33–70.
   Web of Science ®Google Scholar
• Moghassemi S, Hadjizadeh A. Nano-niosomes as nanoscale drug delivery systems: an illustrated review. J Control Release. 2014;185:22–36.
   PubMed Web of Science ®Google Scholar
• Baillie A, Florence A, Hume L, et al. The preparation and properties of niosomes – non-ionic surfactant vesicles. J Pharm Pharmacol. 1985;37(12):863–868.
   PubMed Web of Science ®Google Scholar
• Yoshioka T, Sternberg B, Florence A. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan triester (Span 85). Int J Pharm. 1994;105(1):1–6.
   Web of Science ®Google Scholar
• Manosroi A, Wongtrakul P, Manosroi J, et al. Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol. Colloids Surf B Biointerf. 2003;30(1):129–138.
   Web of Science ®Google Scholar
• Kato K, Walde P, Koine N, et al. Temperature-sensitive nonionic vesicles prepared from Span 80 (sorbitan monooleate). Langmuir. 2008;24(19):10762–10770.
   PubMed Web of Science ®Google Scholar
• Hayashi K, Shimanouchi T, Kato K, et al. Span 80 vesicles have a more fluid, flexible and “wet” surface than phospholipid liposomes. Colloids Surf B Biointerf. 2011; 87(1): 28–35.
   PubMed Web of Science ®Google Scholar
• Hayashi K, Tatsui T, Shimanouchi T, et al. Membrane interaction between Span 80 vesicle and phospholipid vesicle (liposome): Span 80 vesicle can perturb and hemifuse with liposomal membrane. Colloids Surf B Biointerf. 2013;106:258–264.
   PubMed Web of Science ®Google Scholar
• Patel, NA, Patel, NJ, Patel, RP. Comparative development and evaluation of topical gel and cream formulations of psoralen. Drug Discov Ther. 2009;3:234–242.
   PubMedGoogle Scholar
• Tawfik MA, Tadros MI, Mohamed MI. Polyamidoamine (PAMAM) dendrimers as potential release modulators and oral bioavailability enhancers of vardenafil hydrochloride. Pharm Dev Technol. 2018;21:1–10.
   Google Scholar
• Pavelić Z, Skalko-Basnet N, Schubert R. Liposomal gels for vaginal drug delivery. Int J Pharm. 2001; 219(1-2):139–149.
   PubMed Web of Science ®Google Scholar
• Kulkarni SB, Betageri GV, Singh M. Factors affecting microencapsulation of drugs inliposomes. J Microencapsul. 1995;12(3):229–246.
   PubMed Web of Science ®Google Scholar
• Toshimitsu Y, Brigitte S, Florence AT. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitantriester (Span 85). Int J Pharm. 1994;105:1–6.
   Web of Science ®Google Scholar
• Aggarwal D, Garg A, Kaur IP. Development of a topical niosomal preparation ofacetazolamide: preparation and evaluation. J Pharm Pharmacol. 2004;56(12):1509–1517.
   PubMed Web of Science ®Google Scholar
• Hamdy A, Ismail S, Amal K, et al., Preparation of niosomes as an ocular delivery system for naltrexone hydrochloride: physicochemical characterization. Pharmazie. 2010;65(11):811–817.
   PubMed Web of Science ®Google Scholar
• Abdelbary AA, AbouGhaly MH. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study. Int J Pharm. 2015;485(1-2):235–243.
   PubMed Web of Science ®Google Scholar
• Lingan MA, Sathali AAH, Kumar MRV, et al. Formulation and evaluation of topical delivery system containing clobetasol propionate niosomes. Sci Revs ChemCommun. 2011;1(1):7–17.
   Google Scholar
• Pardakhty A, Varshosaz J, Rouholamini A. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J Pharm. 2007;328(2):130–141.
   PubMed Web of Science ®Google Scholar
• Basalious EB, Shawky N, Badr-Eldin SM. SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimization. Int J Pharm. 2010;391(1-2):203–211.
   PubMed Web of Science ®Google Scholar
• Verma P, Pathak K. Therapeutic and cosmeceutical potential of ethosomes: an overview. J Adv Pharm Technol Res. 2010;1(3):274–282.
   PubMedGoogle Scholar
• Smriti K, Kamla P. Cavamax W7 composite psoralen ethosomal gel versus cavamax W7 psoralen solid complex gel for topical delivery: a comparative evaluation. Int J Pharm Invest. 2013;3(4):171–182.
   PubMedGoogle Scholar
• Manconi M, Sinico C, Valenti D. et al. Cutaneous delivery of 8-methoxypsoralen from liposomal and niosomal carriers. J Drug Deliv Sci Technol. 2002;234(1-2):237–248.
   Google Scholar
• Vijay D, Onkar J. Itraconazole niosomes drug delivery system and its antimycotic activity against Candida albicans. ISRN Pharm. 2012;6:52425.
   Google Scholar
• Zhang Y, Zhang K, Wu Z, et al. Evaluation of transdermal salidroside delivery using niosomes via in vitro cellular uptake. Int J Pharm. 2015;478(1):138–146.
   PubMed Web of Science ®Google Scholar
• Abdelkader H, Alani AW, Alany RG. Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations. Drug Deliv. 2014;21(2):87–100.
   PubMed Web of Science ®Google Scholar
• Mali N, Darandale S, Vavia P. Niosomes as a vesicular carrier for topical administration of minoxidil: formulation and in vitro assessment. Drug Deliv Translat Res. 2013;3(6):587–592.
   PubMed Web of Science ®Google Scholar